Infinity Pharmaceuticals, Inc.
INFI
INFI was delisted on the 13th of September, 2023.
55 hedge funds and large institutions have $68.9M invested in Infinity Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 5 closing their positions.
200% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 5
114% more capital invested
Capital invested by funds: $32.2M → $68.9M (+$36.7M)
22% more funds holding
Funds holding: 45 → 55 (+10)
2% less call options, than puts
Call options by funds: $275K | Put options by funds: $282K
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.39M |
| 2 |
Two Sigma Investments
New York
|
+$736K |
| 3 |
Renaissance Technologies
New York
|
+$708K |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$694K |
| 5 |
Two Sigma Advisers
New York
|
+$365K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$346K |
| 2 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$272K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$223K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$151K |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$95.7K |
INFI Hedge Fund Activity: Q4 2020 in Review
55 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q4 2020, worth a combined $68.9M — up 114% from $32.2M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new INFI positions and 5 closed out — a net gain of 10 holders — while 10 added to existing stakes and 12 trimmed.
The largest buyer was Millennium Management, adding an estimated $1.39M. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $346K sold.
- 55 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q4 2020, up from 45 in Q3 2020.
- Funds reported $68.9M of Infinity Pharmaceuticals, Inc. stock for Q4 2020, up 114% quarter-over-quarter.
- 15 funds opened new Infinity Pharmaceuticals, Inc. positions in Q4 2020 and 5 closed out, a net change of +10 holders.
- The largest Infinity Pharmaceuticals, Inc. buyer in Q4 2020 was Millennium Management, an estimated $1.39M added.
- The largest Infinity Pharmaceuticals, Inc. seller in Q4 2020 was Dimensional Fund Advisors, an estimated $346K sold.
Based on aggregated 13F filings for Q4 2020.